GL1X · GenesisL1 explorer

MolNFT v1 · #162089 · protein

Human CSNK2A2 bound to a PYRROLO[2,3-D]PYRIMIDINYL inhibitor

6QY9: “Human CSNK2A2 bound to a PYRROLO[2,3-D]PYRIMIDINYL inhibitor”. X-ray diffraction, 2 ligands (JL2, CL). MolNFT v1 #162089 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6QY9
Type
protein
Length
329 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P19784
Ligands
JL2, CL

Structure

x-ray diffraction · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein329—P19784

Ligands and binding sites

  • JL2 · 3-[3-[2-[(3,4,5-trimethoxyphenyl)amino]pyrrolo[2,3-d]pyrimidin-7-yl]phenyl]propanenitrile · ligand · chains A
  • CL · Chloride ion · ion · 2 copies · chains A
  • EDO · 1,2-ethanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6QY9 · Human CSNK2A2 bound to a Pyrrolo[2,3-d]pyrimidinyl inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • P19784 · AlphaFold monomer V2.0 prediction for casein kinase II subunit alpha' (P19784) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.